3 results
Part 1: To assess the safety and effectiveness of subcutaneous golimumab 50 mg (SC-GLM50), administered by autoinjection once monthly during 6 months, when combined with different DMARD regimens used in daily rheumatology. Part 2: In subjects who…
To determine the effect of the adjuvant application of PRP after NACD on pain reduction, recovery of shoulder function, tendon recovery, resorption of calcific deposits, the percentage of patients with persistent complains and quality of life. The…
To investigate whether the application of dual-site tACS during cognitive training ameliorates spatial neglect symptoms to a larger extent than the application of sham stimulation during cognitive training.